FENTALIS cpr subling 200 mcg 30 pce
7680679960046
CH-67996
N02AB03
01.01.3.
1 / 3
google
Details
- Product number
- 6799602
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- fentanylum 200 µg ut fentanyli citras, mannitolum, cellulosum microcristallinum silicificatum, carmellosum natricum conexum corresp. natrium max. 0.06 mg, magnesii stearas, pro compresso.
Articles (1)
Fentalis 200 μg, Sublingualtabletten
Sublingualtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fentanylum
|
200.0 UG | Substance | Wirkstoff (Principe actif) |
|
fentanyli citras
|
- | Substance | WIZUS |
|
mannitolum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum silicificatum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67996
- Drug name
- Fentalis, Sublingualtabletten
- Galenic form
- SUBL
- ATC Code
- N02AB03
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 27/01/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FENTALIS cpr subling 200 mcg 30 pce
- Description (DE)
- FENTALIS Subling Tabl 200 mcg 30 Stk
- Market launch
- 27/01/2021
- Market withdrawal
- 03/12/2025
- Narcotic (BTM)
- A